Researchers warn that halting federal contracts for mRNA vaccine research could weaken pandemic preparedness and slow medical advances.

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.

Lipid nanoparticles, such as the one shown in this illustration, are used as vehicles to deliver mRNA-based vaccines. The U.S. Department of Health and Human Services announced on Tuesday that it will ...

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...

We recently published 10 Stocks Jim Cramer Discussed As He Warned About Big Risk To Big Tech. Moderna, Inc. (NASDAQ:MRNA) is one of the stocks Jim Cramer recently discussed. Moderna, Inc. (NASDAQ:MRNA ...

On Sept. 4, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. is scheduled to testify before the Senate Finance ...

Charlie Kirk, R.I.P. Why I Am Not Judging Bystanders on the Charlotte Train Russia’s Drone Incursion over Poland Demands a Serious Response Senate Rules Need Not Delay Executive Branch Subordinates ...

An mRNA therapy efficaciously corrected—in a mouse model—altered glutathione metabolism, offering a prospective avenue for treating argininosuccinic aciduria (ASA), an inherited metabolic disorder.

Russia's EnteroMix vaccine, based on mRNA tech, showed 100% efficacy in early cancer trials. Designed to shrink tumours and work without chemo side effects.

Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage” of the revenue generated by Spikevax ...